Hello all,
We intend on carrying out a study with the outcome of interest being how cervicovaginal secretions (CVS) categories of women change over time based on multiple exposures such as contraceptive use etc. The outcome has 3 categories and a previous study had the following proportions among women across the 3 categories 0.42, 0.46 and 0.12. The CVS categories are not ordered however, the categories symbolise the women's susceptibility to infection i.e enhancers (nature of secretion promotes infection), inhibitors (nature of secretion protects them from infection or decreases chances of infection) and the neutral (have no effect).
The hypothesis is with time women's CVS categories will change over time based on the exposure variables such as contraceptive use, sexual activity etc. Women will be followed for up to a year with CVS categories being determined every month for the first 3 months and quarterly for the remainder of the time. In otherwords a woman could have a CVS category of neutral at baseline, then inhibitor at month 2 and then enhancer at month 6 based on the exposure variables.
Any assistance on how to come up with a sample size would be greatly appreciated.
We intend on carrying out a study with the outcome of interest being how cervicovaginal secretions (CVS) categories of women change over time based on multiple exposures such as contraceptive use etc. The outcome has 3 categories and a previous study had the following proportions among women across the 3 categories 0.42, 0.46 and 0.12. The CVS categories are not ordered however, the categories symbolise the women's susceptibility to infection i.e enhancers (nature of secretion promotes infection), inhibitors (nature of secretion protects them from infection or decreases chances of infection) and the neutral (have no effect).
The hypothesis is with time women's CVS categories will change over time based on the exposure variables such as contraceptive use, sexual activity etc. Women will be followed for up to a year with CVS categories being determined every month for the first 3 months and quarterly for the remainder of the time. In otherwords a woman could have a CVS category of neutral at baseline, then inhibitor at month 2 and then enhancer at month 6 based on the exposure variables.
Any assistance on how to come up with a sample size would be greatly appreciated.
Comment